tradingkey.logo

Neogenomics Inc

NEO
11.420USD
+0.150+1.33%
Fechamento 02/06, 16:00ETCotações atrasadas em 15 min
1.47BValor de mercado
PerdaP/L TTM

Neogenomics Inc

11.420
+0.150+1.33%

Mais detalhes de Neogenomics Inc Empresa

NeoGenomics, Inc. is a cancer diagnostics company specializing in cancer genetics testing and information services. The Company offers comprehensive oncology-focused testing menus across the cancer continuum, serving oncologists, pathologists, hospital systems, academic centers, and pharmaceutical firms with diagnostic and predictive testing to help them diagnose and treat cancer. Its services include clinical cancer testing; interpretation and consultative services; molecular and NGS testing; comprehensive technical and professional services offering; clinical trials and research; validation laboratory services, and oncology data solutions. It operates a network of laboratories for full-service sample processing and analysis services throughout the United States and a full-service sample-processing laboratory in Cambridge, United Kingdom. Its testing services include Cytogenetics (karyotype analysis), Fluorescence In-Situ Hybridization (FISH), Flow cytometry, and others.

Informações de Neogenomics Inc

Código da empresaNEO
Nome da EmpresaNeogenomics Inc
Data de listagemDec 10, 2012
CEOZook (Antony P)
Número de funcionários2200
Tipo de títulosOrdinary Share
Fim do ano fiscalDec 10
Endereço9490 Neogenomics Way
CidadeFORT MYERS
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal33912
Telefone12397680600
Sitehttps://neogenomics.com/
Código da empresaNEO
Data de listagemDec 10, 2012
CEOZook (Antony P)

Executivos da empresa Neogenomics Inc

Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Jeffrey Scott (Jeff) Sherman
Mr. Jeffrey Scott (Jeff) Sherman
Chief Financial Officer
Chief Financial Officer
174.72K
-11938.00%
Mr. Warren Stone
Mr. Warren Stone
President, Chief Operating Officer
President, Chief Operating Officer
121.63K
+22127.00%
Mr. Stephen Michael Kanovsky
Mr. Stephen Michael Kanovsky
Independent Director
Independent Director
52.34K
+12254.00%
Dr. Neil Gunn
Dr. Neil Gunn
Independent Director
Independent Director
28.10K
+12254.00%
Ms. Felicia Williams
Ms. Felicia Williams
Independent Director
Independent Director
7.16K
+7160.00%
Ms. Lynn A. Tetrault, J.D.
Ms. Lynn A. Tetrault, J.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Dr. Alison L. Hannah, M.D.
Dr. Alison L. Hannah, M.D.
Independent Director
Independent Director
--
--
Mr. Michael A. Kelly
Mr. Michael A. Kelly
Lead Independent Director
Lead Independent Director
--
--
Mr. David B. Perez
Mr. David B. Perez
Independent Director
Independent Director
--
--
Ms. Alicia Olivo
Ms. Alicia Olivo
Executive Vice President, General Counsel & Business Development
Executive Vice President, General Counsel & Business Development
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Jeffrey Scott (Jeff) Sherman
Mr. Jeffrey Scott (Jeff) Sherman
Chief Financial Officer
Chief Financial Officer
174.72K
-11938.00%
Mr. Warren Stone
Mr. Warren Stone
President, Chief Operating Officer
President, Chief Operating Officer
121.63K
+22127.00%
Mr. Stephen Michael Kanovsky
Mr. Stephen Michael Kanovsky
Independent Director
Independent Director
52.34K
+12254.00%
Dr. Neil Gunn
Dr. Neil Gunn
Independent Director
Independent Director
28.10K
+12254.00%
Ms. Felicia Williams
Ms. Felicia Williams
Independent Director
Independent Director
7.16K
+7160.00%
Ms. Lynn A. Tetrault, J.D.
Ms. Lynn A. Tetrault, J.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--

Detalhamento da receita

Moeda: USDAtualizado em: ter, 6 de jan
Moeda: USDAtualizado em: ter, 6 de jan
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
Por EmpresaUSD
Nome
Receita
Proporção
Clinical Services-Client direct billing
132.29M
70.44%
Clinical Services-Commercial Insurance
32.47M
17.29%
Clinical Services-Medicare and Medicaid
22.97M
12.23%
Clinical Services-Self-Pay
69.00K
0.04%
Os dados relevantes ainda não foram divulgados pela empresa.
Por Empresa
Por Região
Por EmpresaUSD
Nome
Receita
Proporção
Clinical Services-Client direct billing
132.29M
70.44%
Clinical Services-Commercial Insurance
32.47M
17.29%
Clinical Services-Medicare and Medicaid
22.97M
12.23%
Clinical Services-Self-Pay
69.00K
0.04%

Distribuição de ações

Atualizado em: qua, 4 de fev
Atualizado em: qua, 4 de fev
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
BlackRock Institutional Trust Company, N.A.
13.59%
The Vanguard Group, Inc.
10.66%
First Light Asset Management, LLC
7.67%
Greenhouse Funds LLLP
6.35%
Millennium Management LLC
5.01%
Outro
56.71%
Investidores
Investidores
Proporção
BlackRock Institutional Trust Company, N.A.
13.59%
The Vanguard Group, Inc.
10.66%
First Light Asset Management, LLC
7.67%
Greenhouse Funds LLLP
6.35%
Millennium Management LLC
5.01%
Outro
56.71%
Tipos de investidores
Investidores
Proporção
Investment Advisor
48.68%
Investment Advisor/Hedge Fund
31.58%
Hedge Fund
23.57%
Research Firm
2.97%
Individual Investor
1.31%
Pension Fund
1.26%
Bank and Trust
0.54%
Sovereign Wealth Fund
0.09%
Family Office
0.04%

Participação acionária institucional

Atualizado em: seg, 5 de jan
Atualizado em: seg, 5 de jan
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q4
572
134.68M
104.09%
-7.79M
2025Q3
568
127.88M
98.83%
-9.78M
2025Q2
571
126.82M
98.17%
-12.95M
2025Q1
596
131.44M
102.13%
-4.71M
2024Q4
585
127.59M
99.32%
-7.82M
2024Q3
589
129.38M
100.96%
-8.76M
2024Q2
597
131.21M
102.74%
-9.36M
2024Q1
633
132.83M
104.04%
-13.13M
2023Q4
672
130.90M
102.70%
-12.18M
2023Q3
691
124.98M
98.00%
-16.78M
Ver Mais

Atividade dos acionistas

Nome
Ações detidas
Proporção
Variação
Var. %
Data
BlackRock Institutional Trust Company, N.A.
17.58M
13.59%
-189.58K
-1.07%
Sep 30, 2025
The Vanguard Group, Inc.
13.87M
10.72%
-227.03K
-1.61%
Sep 30, 2025
First Light Asset Management, LLC
9.93M
7.67%
+3.08M
+45.00%
Sep 30, 2025
Greenhouse Funds LLLP
8.22M
6.35%
+789.51K
+10.62%
Sep 30, 2025
Millennium Management LLC
6.48M
5.01%
+46.65K
+0.72%
Dec 02, 2025
State Street Investment Management (US)
5.02M
3.88%
-88.88K
-1.74%
Sep 30, 2025
Deerfield Management Company, L.P.
4.45M
3.44%
+2.30M
+107.05%
Sep 30, 2025
Dimensional Fund Advisors, L.P.
3.83M
2.96%
-465.84K
-10.85%
Sep 30, 2025
Schroder Investment Management North America Inc.
3.48M
2.69%
-240.87K
-6.47%
Sep 30, 2025
Ver Mais

ETFs Relacionados

Atualizado em: sáb, 6 de dez
Atualizado em: sáb, 6 de dez
Nome
Proporção
State Street SPDR S&P Health Care Services ETF
2.38%
Invesco S&P SmallCap Health Care ETF
0.77%
First Trust Nasdaq Lux Digi Health Solutions ETF
0.5%
Inspire Small/Mid Cap ESG ETF
0.32%
iShares U.S. Healthcare Providers ETF
0.2%
Invesco S&P SmallCap 600 QVM Multi-factor ETF
0.14%
iShares S&P Small-Cap 600 Value ETF
0.12%
Nuveen ESG Small-Cap ETF
0.11%
iShares ESG Select Screened S&P Small-Cap ETF
0.1%
iShares Core S&P Small-Cap ETF
0.09%
Ver Mais
State Street SPDR S&P Health Care Services ETF
Proporção2.38%
Invesco S&P SmallCap Health Care ETF
Proporção0.77%
First Trust Nasdaq Lux Digi Health Solutions ETF
Proporção0.5%
Inspire Small/Mid Cap ESG ETF
Proporção0.32%
iShares U.S. Healthcare Providers ETF
Proporção0.2%
Invesco S&P SmallCap 600 QVM Multi-factor ETF
Proporção0.14%
iShares S&P Small-Cap 600 Value ETF
Proporção0.12%
Nuveen ESG Small-Cap ETF
Proporção0.11%
iShares ESG Select Screened S&P Small-Cap ETF
Proporção0.1%
iShares Core S&P Small-Cap ETF
Proporção0.09%

Dividendo

Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados

Desdobramento de ações

Data
Data ex-dividendo
Tipo
Proporção
Sem dados
Data
Data ex-dividendo
Tipo
Proporção
Sem dados
KeyAI